Literature DB >> 16041837

A note on the antitubercular activities of 1-aryl-5-benzylsulfanyltetrazoles.

Jan Adamec1, Karel Waisser, Jirí Kunes, Jarmila Kaustová.   

Abstract

A set of 32 1-phenyl-5-benzylsulfanyltetrazoles substituted on the phenyl ring as well as on the benzyl moiety was synthesized. The compounds were evaluated for in vitro antimycobacterial activity against Mycobacterium tuberculosis. The activity against M. tuberculosis becomes higher with increasing electron-accepting properties of the substituents on the phenyl ring. On the other hand, any substitution on the benzylic moiety decreases the activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16041837     DOI: 10.1002/ardp.200400967

Source DB:  PubMed          Journal:  Arch Pharm (Weinheim)        ISSN: 0365-6233            Impact factor:   3.751


  4 in total

1.  1-Aryl-5-benzylsulfanyltetrazoles, a new group of antimycobacterial compounds against potentially pathogenic strains.

Authors:  K Waisser; J Adamec; R Dolezal; J Kaustová
Journal:  Folia Microbiol (Praha)       Date:  2005       Impact factor: 2.099

2.  In vitro evaluation of tetrazoles as a novel class of Antimycobacterium tuberculosis agents.

Authors:  P B Mohite; V H Bhaskar
Journal:  Adv Pharm Bull       Date:  2012-02-15

3.  New endoperoxides highly active in vivo and in vitro against artemisinin-resistant Plasmodium falciparum.

Authors:  Lis Lobo; Lília I L Cabral; Maria Inês Sena; Bruno Guerreiro; António Sebastião Rodrigues; Valter Ferreira de Andrade-Neto; Maria L S Cristiano; Fatima Nogueira
Journal:  Malar J       Date:  2018-04-03       Impact factor: 2.979

4.  Microwave-assisted efficient one-pot synthesis of N 2-(tetrazol-5-yl)-6-aryl/heteroaryl-5,6-dihydro-1,3,5-triazine-2,4-diamines.

Authors:  Moustafa Sherief Moustafa; Ramadan Ahmed Mekheimer; Saleh Mohammed Al-Mousawi; Mohamed Abd-Elmonem; Hesham El-Zorba; Afaf Mohamed Abdel Hameed; Tahany Mahmoud Mohamed; Kamal Usef Sadek
Journal:  Beilstein J Org Chem       Date:  2020-07-16       Impact factor: 2.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.